|
Alzheimer's Combo Treatment OKd by FDA
Newsmax Health The U.S. Food and Drug Administration approved a drug to treat dementia in Alzheimer's patients that was developed by Actavis and Adamas Pharmaceuticals. Adamas shares were up nearly 17 percent at $17.10 in premarket trading. The drug, Namzaric is … |
